The ribosomal protein S6 kinase A2 (RPS6KA2) functions as a tumor suppressor gene and is commonly subject to deletion or downregulation, with studies identifying its abnormal expression as a potential marker of poor prognosis in breast cancer, glioblastoma, and prostate cancer [17–19]. The gene discussed is RPS6KA2; the disease is prostate carcinoma.